Simultaneous multicentric occurrence of early hepatocellular carcinoma in a patient with persistent alpha-fetoprotein elevation

Hepatology Research

Volumn 37, Issue 11, 2007, Pages 988-989

  Toyoda, Hidenori ^a   Kumada, Takashi ^a   Kiriyama, Seiki ^a   Sone, Yasuhiro ^a   Tanikawa, Makoto ^a   Hisanaga, Yasuhiro ^a   Kanamori, Akira ^a  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; TUMOR MARKER;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE MARKER; ECHOGRAPHY; FEMALE; HUMAN; LETTER; LIVER ANGIOGRAPHY; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER NODULE; MULTIPLE CANCER; NEEDLE BIOPSY; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOFREQUENCY ABLATION;

EID: 34548651699     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00155.x     Document Type: Letter

References (10)

1. Tsukuma H, Hiyama T, Tanaka S et al. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 1993; 328: 1797-801.
2. Oka H, Tamori A, Kuroki T, Kobayashi K, Yamamoto S. Prospective study of alpha-fetoprotein in cirrhotic patients monitored for development of hepatocellular carcinoma. Hepatology 1994; 19: 61-6.
3. Murakami T, Oi H, Hori M et al. Helical CT during arterial portography and hepatic arteriography for detecting hypervascular hepatocellular carcinoma. Am J Roentgenol 1997; 169: 131-5.
4. Kudo M. Imaging blood flow characteristics of hepatocellular carcinoma. Oncology 2002; 62: S48-56.
5. Kojiro M. "Nodule-in-nodule"appearance in hepatocellular carcinoma: Its significance as a morphologic marker of dedifferentiation. Intervirology 2004; 47: 179-83.
6. Sakamoto M, Hirohashi S, Shimosato Y. Early stages of hepatocarcinogenesis: Adenomatous hyperplasia and early hepatocellular carcinoma. Hum Pathol 1991; 22: 172-8.
7. Takenaka K, Adachi E, Nishizaki T et al. Possible multicentric occurrence of hepatocellular carcinoma: A clinicopathological study. Hepatology 1994; 19: 889-94.
8. Fujiyama S, Tanaka M, Maeda S, Ashihara H, Hirata R, Tomita K. Tumor markers in early diagnosis, follow-up and management of patients with hepatocellular carcinoma. Oncology 2002; 62: S57-63.
9. Hu K-Q, Kyulo NL, Lim N, Elhazin B, Hillebrand DJ, Bock T. Clinical significance of elevated alpha-fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol 2004; 99: 860-5.
10. Llovet JM. Hepatocellular carcinoma: Patients with increasing alpha-fetoprotein but no mass on ultrasound. Clin Gastroenterol Hepatol 2006; 4: 29-35.